Chemino Pharma Limited - Company Profile

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 2018.
2018 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Chemino Pharma Limited

Chemino Pharma Limited, a active public limited company, was established on 29 August 2018 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U33100MH2018PLC313189. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹25.00 Cr and a paid-up capital of ₹24.60 Cr.

Formerly known as Chemino Pharma Private Limited, Insunt Trading Private Limited. It upholds a compliant status. Employing 25 professional, Its leadership includes Kiran Parmanand Goklani (Director), Shriraj Sadashiv Shetty (Whole-Time Director), Chandan Dashrathsingh Rajpurohit (Director). Past directors included Kiran Parmanand Goklani, Kalpesh Balwantbhai Donga, Shriraj Sadashiv Shetty. It holds ₹97.19 Cr open charges and ₹35.00 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Office No. 303,3Rd Floor,Western Edge 1,C.T.S. No 163 &165-A Dattapada Road,Borivali East,, Magathane, Mumbai, Maharashtra, 400066.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U33100MH2018PLC313189

  • Registration Number

    313189

  • Incorporation Date

    29 August 2018

  • Authorized Capital

    ₹25.00 Cr

  • Paid-Up Capital

    ₹24.60 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 25.00 Cr
  • Paid Up Capital ₹ 24.60 Cr
  • Company Age 7 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 97.19 Cr
  • Satisfied Charges ₹ 35.00 Cr
  • Revenue Growth **** 4824.59%
  • Profit Growth **** 296.63%
  • Ebitda **** -249.27%
  • Net Worth 5.85%
  • Total Assets **** 252.78%
Company report

Chemino Pharma Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Chemino Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Chemino Pharma Limited?
Current Directors
Name Designation Appointment Date Status
Kiran Parmanand Goklani Director 20 Feb 2025 Current
Shriraj Sadashiv Shetty Whole-Time Director 29 Aug 2018 Current
Chandan Dashrathsingh Rajpurohit Director 20 Mar 2025 Current
Meghraj Doddanna Shetty Director 01 Apr 2023 Current
Sadashiv Kanyana Shetty Managing Director 29 Aug 2018 Current
Shreya Sadashiv Shetty Director 27 Oct 2021 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 29 Sep 2025 Past
Pramod Abcsdd Director 27 Oct 2021 Past
Pramod Abcsdd Director 16 Mar 2023 Past
Pramod Abcsdd Cfo - Past
Pramod Abcsdd Additional Director 29 Sep 2025 Past
Pramod Abcsdd Additional Director 29 Sep 2023 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Chemino Pharma.

Chemino Pharma Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 4824.59% increase. The company also saw a substantial improvement in profitability, with a 296.63% increase in profit. The company's net worth moved up by a moderate rise of 5.85%.

Chemino Pharma revenue growth over time
Chemino Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 4824.59%
*******
*******
*******
*******
Revenue from Operations
*******
 5813.48%
*******
*******
*******
*******
Total Assets
*******
 252.78%
*******
*******
*******
*******
Profit or Loss
*******
 296.63%
*******
*******
*******
*******
Net Worth
*******
 5.85%
*******
*******
*******
*******
EBITDA
*******
 -249.27%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Chemino Pharma?

In 2023, Chemino Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹971,893,000.00

Satisfied Charges

₹350,000,000.00

Charges Breakdown by Lending Institutions
  • Others : 96.46 Cr
  • Hdfc Bank Limited : 0.73 Cr
Latest Charge Details
Date Lender Amount Status
18 Sep 2025 Others ₹1.46 Cr Open
28 Mar 2024 Others ₹8.70 M Open
28 Mar 2024 Others ₹9.13 Cr Open
25 Oct 2022 Hdfc Bank Limited ₹7.29 M Open
27 Jul 2022 Others ₹85.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Chemino Pharma?

Chemino Pharma has a workforce of 25 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Chemino Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chemino Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Chemino Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Chemino Pharma Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Charges

    The activity A charge with Others amounted to Rs. 1.46 Cr with Charge ID 101164885 was registered on 18 Sep 2025. was completed.

  • Balance Sheet

    Progress on Chemino Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.

  • Director Appointment

    Progress on Chandan Dashrathsingh Rajpurohit was appointed as a Director was appointed as a Director on 20 Mar 2025 & has been associated with this company since 10 months 27 days . was documented.

  • Director Appointment

    The activity Kiran Parmanand Goklani was appointed as a Director was appointed as a Director on 20 Feb 2025 & has been associated with this company since 11 months 25 days . was completed.

  • Director Appointment

    Nitin Suresh Belose was appointed as a Cfo was appointed as a Cfo on 09 Jan 2025 & has been associated with this company since 1 year 1 month . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Chemino Pharma Limited?

The CIN of Chemino Pharma Limited is U33100MH2018PLC313189.

Where is Chemino Pharma Limited headquartered?

Chemino Pharma Limited is headquartered at Office No. 303,3Rd Floor,Western Edge 1,C.T.S. No 163 &165-A Dattapada Road,Borivali East,, Magathane, Mumbai, Maharashtra, 400066.

When was Chemino Pharma Limited incorporated?

Chemino Pharma Limited was incorporated on 29 August 2018.

Who are the current directors of Chemino Pharma Limited?

The current directors of Chemino Pharma Limited are

What is the primary industry of Chemino Pharma Limited?

The primary industry of Chemino Pharma Limited is Manufacturing.

Is Chemino Pharma Limited a listed company?

Chemino Pharma Limited is unlisted.

What is the capital structure of Chemino Pharma Limited?

The authorized capital of Chemino Pharma Limited is ₹25.00 Cr, and the paid-up capital is ₹24.60 Cr.

What is the compliance status of Chemino Pharma Limited?

The compliance status of Chemino Pharma Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available